Cancer is one of the leading causes of death and disability, affecting millions of working-age adults and their families each ...

NCCN now recognizes personalized, tumor-informed ctDNA-MRD as a prognostic and predictive biomarker in MIBC, extending ...

Public health has been waiting two decades1,2 for signs that human papillomavirus (HPV) vaccination prevents deaths, not only precancerous lesions and cancer. Studies in countries where HPV ...

Home-based human papillomavirus screening for cervical cancer shows modest uptake in a diverse community setting.

The federal government has launched a new advisory committee on preventive health care more than a year after pausing the work of a task force that had come under fire for failing to keep up with ...

Nearly 18 million women in the U.S. aged 45 to 64 years are likely overdue for breast, cervical or colorectal cancer screenings, and more than 3 million are estimated to not be up to date on all three ...

Our findings provide the first robust national-level evidence, albeit observational, that high HPV vaccination coverage is associated with a substantial reduction in cervical cancer deaths. This is ...